MCRB
$9.35
Seres Therapeutics
($.32)
(3.31%)
MCRB
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.53)
Revenue:  $6.41 Mil
Wednesday
Feb 9
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when MCRB reports earnings?
Beat
Meet
Miss

Where is MCRB's stock price going from here?
Up
Flat
Down
Stock chart of MCRB
Analysts
Summary of analysts' recommendations for MCRB
Score
Grade
Pivots
Resistance
$10.80
$10.38
$9.86

$9.44

Support
$8.92
$8.50
$7.98
Tweet
Growth
Description
Seres Therapeutics, Inc. offers microbiome therapeutics platform. It is focused on developing Ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. Seres Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.